2C-T-17

{{chembox

| Verifiedfields = changed

| Watchedfields = changed

| verifiedrevid = 477216604

| ImageFile1 = 2C-T-17 2DACS.svg

| ImageSize1 = 180px

| ImageFile2 = 2C-T-17-3d-sticks.png

| ImageSize3 = 180px

| PIN = 2-{4-[(Butan-2-yl)sulfanyl]-2,5-dimethoxyphenyl}ethan-1-amine

| OtherNames =

|Section1={{Chembox Identifiers

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 21106230

| InChI = 1/C14H23NO2S/c1-5-10(2)18-14-9-12(16-3)11(6-7-15)8-13(14)17-4/h8-10H,5-7,15H2,1-4H3

| InChIKey = KSZHVRPGICAZOA-UHFFFAOYAV

| ChEMBL_Ref = {{ebicite|correct|EBI}}

| ChEMBL = 127284

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C14H23NO2S/c1-5-10(2)18-14-9-12(16-3)11(6-7-15)8-13(14)17-4/h8-10H,5-7,15H2,1-4H3

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = KSZHVRPGICAZOA-UHFFFAOYSA-N

| CASNo_Ref = {{cascite|correct|chemspider}}

| CASNo = 207740-32-7

| PubChem = 44349798

| UNII = NLC3VH4KZM

| SMILES = CC(CC)Sc1cc(OC)c(cc1OC)CCN

}}

|Section2={{Chembox Properties

| Formula =

| C=14 | H=23 | N=1 | O=2 | S=1

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

2C-T-17, also known as 4-sec-butylthio-2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book PiHKAL (Phenethylamines i Have Known And Loved).

Chemistry

2C-T-17 is the 2 carbon homologue of Aleph-17, which has never been synthesized. The full chemical name is 2-[4-(2-butyl thio)-2,5-dimethoxy phenyl]ethanamine. The drug has structural properties similar to drugs in the 2C-T series, with the most closely related compounds being 2C-T-7 and 2C-T-8.

General information

The dosage range of 2C-T-17 is typically 60-100 mg and its duration is approximately 10–15 hours according to Shulgin. 2C-T-17 has highly psychedelic effects on thinking, but produces few to no visuals.{{CitePiHKAL}}

Pharmacology

The mechanism that produces 2C-T-17's hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a 5-HT2A serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.

Dangers

The toxicity of 2C-T-17 is not well documented. 2C-T-17 is much less potent than 2C-T-7, but it may be expected that at very high doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.

Legality

2C-T-17 is not illegal, but possession and sales of 2C-T-17 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.

=Canada=

As of October 31, 2016, 2C-T-17 is a controlled substance (Schedule III) in Canada.{{Cite web|url=http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php|title=Canada Gazette – Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)|date=4 May 2016}}

=United Kingdom=

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.{{cite web | title = UK Misuse of Drugs act 2001 Amendment summary | url = http://isomerdesign.com/Cdsa/scheduleUK.php?schedule=1&ion=30&structure=C | access-date = 12 March 2014 | publisher = Isomer Design}}

See also

References

{{reflist}}